Loeb & Loeb represented Liminatus Pharma, while Holland & Knight advised Iris Acquisition Corp. on the transaction.Liminatus Pharma LLC, a clinical-stage biopharmaceutical company developing novel, immune-modulating…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
